The role of environmental estrogens and autoimmunity

Autoimmunity Reviews

Volumn 11, Issue 6-7, 2012, Pages

  Chighizola, Cecilia ^a   Meroni, Pier Luigi ^b  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Autoimmunity; Environmental estrogens; Immune system

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ALDICARB; ANDROSTANOLONE; ANTINUCLEAR ANTIBODY; CHLORDANE; CHLORPHENOTANE; DAIDZEIN; DIETHYLSTILBESTROL; DITHIOCARBAMIC ACID; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GAMMA INTERFERON; GENISTEIN; HEXACHLOROBENZENE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; METHOXYCHLOR; PENTACHLOROPHENOL; PHYTOESTROGEN; PRASTERONE; PRASTERONE SULFATE; PROPANIL; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ZEARALENONE;

ALLERGY; ANTIBODY PRODUCTION; ARTHRITIS; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CARCINOGENICITY; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL NUCLEUS; CYTOKINE PRODUCTION; CYTOPLASM; DENDRITIC CELL; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG MEGADOSE; ENVIRONMENTAL EXPOSURE; GRAFT VERSUS HOST REACTION; HORMONE METABOLISM; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOTOXICITY; INFLAMMATION; MACROPHAGE; MAST CELL DEGRANULATION; MENOPAUSE; MENSTRUAL CYCLE; MILK PRODUCTION; MITOGENICITY; NATURAL KILLER CELL; NONHUMAN; OCCUPATIONAL EXPOSURE; OTITIS MEDIA; OXIDATIVE STRESS; PATHOGENESIS; PRENATAL EXPOSURE; REVIEW; RHEUMATIC DISEASE; SPLEEN CELL; SPLENOMEGALY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 CELL; TH2 CELL; THYMUS ATROPHY; UROGENITAL TRACT DISEASE; VAGINA CANCER;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; ESTROGENS; ESTROGENS, NON-STEROIDAL; FOOD CONTAMINATION; HUMANS; PHYTOESTROGENS;

EID: 84858445494     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.11.027     Document Type: Review

References (96)

1. Cutolo M., Straub R.H. Insights into endocrine-immunological disturbances in autoimmunity and their impact on treatment. Arthritis Res Ther 2009, 11:218-225.
2. Straub R.H. The complex role of estrogens in inflammation. Endocr Rev 2007, 28:521-574.
3. Ansar Ahmed S. The immune system as a potential target for environmental estrogens (endocrine disrupters): a new emerging field. Toxicology 2000, 150:191-206.
4. Karpuzoglu E., Zouali M. The multi-faceted influences of estrogen on lymphocytes: toward novel immuno-interventions strategies for autoimmunity management. Clinic Rev All Immunol 2011, 40:16-26.
5. Gonzalez D.A., Diaz B.B., Rodriguez Pereza M., Hernandez Gonzalez A., Diaz Chico B.N., Cabrera de Leon A. Sex hormones and autoimmunity. Immunol Lett 2010, 133:6-13.
6. Polischuk S.C., Letcher R.J., Norstrom R.J., Ramsay M.A. Preliminary results of fasting on the kinetics of organochlorines in polar bears (Ursus maritimus). Sci Total Environ 1995, 160:465-472.
7. Soto A.M., Sonnenschein C., Chung K.L., Fernandez M.F., Olea N., Serrano F.O. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect 1995, 103:113-122.
8. Gray L.E., Ostby J., Wilson V., et al. Xenoendocrine disrupters-tiered screening and testing: filling key data gaps. Toxicology 2002, 181:371-382.
9. Marselos M., Tomatis L. Diethylstilboestrol. I: pharmacology, toxicology and carcinogenicity in humans. Eur J Cancer 1992, 28A:1182-1189.
10. Herbst A.L., Ufelder H., Poskanzer D.C. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971, 284:878-881.
11. Marselos M., Tomatis L. Diethylstilboestrol. II: pharmacology, toxicology and carcinogenicity in experimental animals. Eur J Cancer 1993, 29A:149-153.
12. DES Task Force Report Washington 1978, US Government Printing Office, DC.
13. Noller K.L., Blair P.B., O'Brien P.C., et al. Increased occurrence of autoimmune disease among women expose in utero to diethylstilbestrol. Fertili Ster 1988, 49:1080-1082.
14. Wingard D.L., Turiel J.L. Long-term effects of exposure to diethylstilbestrol. West J Med 1988, 149:551-554.
15. Hansar Ahmed S., Hissong B.D., Verthelyi K., Donner K., Becker K., Karpuzoglu-Sahin E. Gender and autoimmune diseases: possible role of estrogenic compounds. Environ Health Perspect 1999, 107:681-687.
16. Corsini E., Liesivuori J., Vergieva T., Van Loveren H., Colosio C. Effects of pesticide exposure on the human immune system. Human & Exp Toxicol 2008, 27:671-680.
17. Frost L.L., Neeley Y.X., Schafer R., Gibson L.F., Barnett J.B. Propanil inhibits tumor necrosis factor-alpha production by reducing nuclear levels of the transcription factor nuclear factor-kappaB in the macrophage cell line ic-21. Toxicol Appl Pharmacol 2001, 172:186-193.
18. Corsini E., Viviani B., Birindelli S., et al. Molecular mechanisms underlying mancozeb-induced inhibition of TNF-alpha production. Toxicol Appl Pharmacol 2006, 212:89-98.
19. Patisaul H.B., Jefferson W. The pros and cons of phytoestrogens. Front Neuroendocrinol 2010, 31:400-419.
20. Guo T.L., McCay J.A., Zhang L.X., et al. Genistein modulates immune responses and increases host resistance to B16F10 tumor in adult female B6C3F1 mice. J Nutrition 2001, 131:3251-3258.
21. Zhang R., Li Y., Wang W. Enhancement of immune function in mice fed high doses of soy daidzein. Nutr Cancer 1997, 24-28.
22. Hämäläinen M., Nieminen R., Vuorela P., Heinonen M., Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in a activated macrophages. Mediators Inflamm 2007, 10.1155/2007/45673.
23. Yum M.K., Jung M.Y., Cho D., Kim T.S. Suppression of dendritic cells' maturation and functions by daidzein, a phytoestrogen. Toxicol Appl Pharmacol 2011, 10.1016/j.taap.2011.09.002.
24. Marin D.E., Taranu I., Burlacu R., et al. Effects of zearalenone and its derivatives on porcine immune response. Toxicol In Vitro 2011, 25:1981-1988.
25. Karagezian M.K. Effect of the mycotoxin zearalenone on the metabolism of membrane phospholipids of rat lymphocytes. Ukr Biokhim Zh 2000, 72:105-109.
26. Marin M.L., Murtha J., Dong W., Pestka J.J. Effects of mycotoxins on cytokine production and proliferation in EL-4 thymoma cells. J Toxicol Environ Health 1996, 48:379-396.
27. Atkinson H.A., Miller K. Inhibitory effect of deoxynivalenol, 3-acetyldeoxynivalenol and zearalenone on induction of rat and human lymphocyte proliferation. Toxicol Lett 1984, 23:215-221.
28. Daxenberger A., Ibarreta D., Meyer H.H.D. Possible health impact of animal oestrogens in food. Hum Reprod Update 2001, 7:340-355.
29. Hengstler J.G., Foth H., Gebel T., et al. Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A. Crit Rev Toxicol 2011, 41:263-291.
30. Inadera H., Sekiya T., Yoshimura T., Matsushima K. Molecular analysis of the inhibition of monocyte chemoattractant protein-1 gene expression by estrogens and xenoestrogens in MCF-7 cells. Endocrinology 2000, 141:50-59.
31. Segura J.J., Jimenez-Rubio A., Pulgar R., Olea N., Guerrero J.M., Calvo J.R. In vitro effect of the resin component bisphenol A on substrate adherence capacity of macrophages. J Endod 1999, 5:341-344.
32. Nair-Menon J.U., Campbell G.T., Blake C.A. Toxic effects of octylphenol on cultured rat and murine splenocytes. Toxicol Appl Pharmacol 1996, 139:437-444.
33. Blake C.A., Nair-Menon J.U., Campbell G.T. Estrogen can protect splenocytes from the toxic effects of the environmental pollutant 4-tert-octylphenol. Endocrine 1997, 6:243-249.
34. Ruh M.F., Bi Y., Cox L., Berk D., Howlett A.C., Bellone C.J. Effects of environmental estrogens on IL-1beta promoter activity in a macrophage cell line. Endocrine 1998, 9:207-211.
35. Dewailly E., Ayotte P., Burneau S., et al. Susceptibility to infections and immune status in Inuit infants exposed to organochlorines. Environ Health Perspect 2000, 108:205-221.
36. Vine M.F., Stein L., Weigle K., et al. Effects on the immune system associated with living near a pesticide dump site. Environ Health Perspect 2000, 108:1113-1124.
37. Costa M.C., Schvartsman S. Antibody titers and blood levels of DDT after diphtheric immunization in children. Acta Pharmacol Toxicol (Copenhagen) 1977, 41:249.
38. Sunyer J., Torrent M., Garcia-Esteban R., et al. Early exposure to dichlorodiphenyldichloroethylene, breastfeeding and asthma at age six. Clin Exp Allergy 2006, 36:1236-1241.
39. Narita S., Goldblum R.M., Watson C.S., et al. Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators. Environ Health Perspect 2007, 115:48-52.
40. Sunyer J., Torrent M., Munoz-Ortiz L., et al. Prenatal dichlorodiphenyldichloroethylene (DDE) and asthma in children. Environ Health Perspect 2005, 113:1787-1790.
41. Li J., Murray R.W. Effects of chronic exposure to DDT and TCDD on disease activity in murine systemic lupus erythematosus. Lupus 2009, 18:941-949.
42. Menconi S., Clark J.M., Langenberg P., Hryhorczuk D. A preliminary study of potential human health effects in private residences following chlordane applications for termite control. Arch Environ Health 1988, 43:349-352.
43. McConnachie P.R., Zahalsky A.C. Immune alterations in humans exposed to the termiticide technical chlordane. Arch Environ Health 1992, 47:295-301.
44. Rosenberg Am A.M., Semchuk K.M., McDuffie HH H.H., et al. Prevalence of antinuclear antibodies in a rural population. J Toxicol Environ Health A 1999, 57:225-236.
45. Blyler G., Landreth K.S., Barnett J.B. Gender-specific effects of prenatal chlordane exposure on myeloid cell development. Fundam Appl Toxicol 1994, 23:188-193.
46. Queiroz M.L.S., Bincoletto C., Perlingeiro R.C.R., Quadros M.R., Souza C.A. Immunoglobulin levels in workers exposed to hexachlorobenzene. Hum Exp Toxicol 1998, 7:172-175.
47. Michielsen C.C., van Loveren H., Vos J.G. The role of the immune system in hexachlorobenzene-induced toxicity. Environ Health Perspect 1999, 107:783-792.
48. Queiroz M.L., Bincoletto C., Perlingeiro R.C., Souza C.A., Toledo H. Defective neutrophil function in workers occupationally exposed to hexachlorobenzene. Hum Exp Toxicol 1997, 16:322-326.
49. Daniel V., Huber W., Bauer K., Suesal C., Conradt C., Opelz G. Associations of blood levels of PCB, HCHs, and HCB with numbers of lymphocyte subpopulations, in vitro lymphocyte response, plasma cytokine levels, and immunoglobulin autoantibodies. Environ Health Perspect 2001, 109:173-178.
50. Michielsen C.P., Bloksma N., Ultee A., van Mil F., Vos J.G. Hexachlorobenzene-induced immunomodulation and skin and lung lesions: a comparison between brown Norway, Lewis, and Wistar rats. Toxicol Appl Pharmacol 1997, 44:12-26.
51. Mirkin I.R., Anderson H.A., Hanrahan L., Hong R., Golubjatnikov R., Belluck D. Changes in T-lymphocyte distribution associated with ingestion of aldicarb-contaminated drinking water: a follow-up study. Environ Res 1990, 51:35-50.
52. Zheng M.H., Zhang B., Bao Z.C., Yang H., Xu X.B. Analysis of pentachlorophenol from water, sediments, and fish bile of Dongting lake in China. Bull Environ Contam Toxicol 2000, 64:16-19.
53. Zhao B., Yang J., Liu Z., Xu Z., Qiu Y., Sheng G. Joint anti-estrogenic effects of PCP and TCDD in primary cultures of juvenile goldfish hepatocytes using vitellogenin as a biomarker. Chemosphere 2006, 65:359-364.
54. Colosio C., Maroni M., Barcellini W., Meroni P., Alcini D., Colombi A., et al. Toxicological and immune findings in workers exposed to pentachlorophenol (PCP). Arch Environ Health 1993, 48:81-88.
55. McConnachie P.R., Zahlsky A.C. Immunological consequences of exposure to pentachlorophenol. Arch Environ Health 1991, 46:249-253.
56. Klemmer H.W., Wong L., Sato M.M., Reichert E.L., Korsak R.J., Rashad M.N. Clinical findings in workers exposed to pentachlorophenol. Arch Environ Contam Toxicol 1980, 9:715-725.
57. Faustini A., Settimi L., Pacifici R., Fano V., Zuccaro P., Forastiere F. Immunological changes among farmers exposed to phenoxy herbicides: preliminary observations. Occup Environ Med 1996, 53:583-585.
58. Reed A., Dzon L., Loganathan B.G., Whalen M.M. Immunomodulation of human natural killer cell cytotoxicity function by organochlorine pesticides. Hum Exp Toxicol 2004, 23:463-471.
59. Esa A.H., Warr G.A., Newcombe D.S. Immunotoxicity of organophosphorus compounds. Modulation of cell mediated immune responses by inhibition of monocyte accessory functions. Clin Immunol Immunopathol 1988, 49:41-52.
60. Thrasher J.D., Madison R., Broughton A. Immunologic abnormalities in humans exposed to chlorpyrifos: preliminary observations. Arch Environ Health 1993, 48:89-93.
61. Cooper G.S., Parks C.G., Schur P.S., Fraser P.A. Occupational and environmental associations with antinuclear antibodies in a general population sample. J Toxicol Environ Health 2006, 69:2063-2069.
62. Cooper G.S., Parks C.G., Treadwell E.L., St Clair E.W., Gilkeson G.S., Dooley M.A. Occupational risk factors for the development of systemic lupus erythematosus. J Rheumatol 2004, 31:1928-1933.
63. Lee D.H., Steffes M., Jacobs D.R. Positive associations of serum concentration of polychlorinated biphenyls or organochlorine pesticides with self-reported arthritis, especially rheumatoid type, in women. Environ Health Perspect 2007, 115:883-888.
64. Cooper G.S., Miller F.W., Germolec D.R. Occupational exposures and autoimmune diseases. Int Immunopharmacol 2002, 2:303-313.
65. Parks C.G., Walitt B.T., Pettinger M., et al. Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the Women's Health Initiative Observational Study. Arthritis Care Res (Hoboken) 2011, 63:184-194.
66. Weisglas-Kusperus N., Vreugdenhil H.J., Mulder P.G. Immunological effects of environmental exposure to polychlorinated byphenils and dioxin in Dutch school children. Toxicol Lett 2004, 149:281-285.
67. Tryphonas H. Immunotoxicity of PCBs (Aroclors) in relation to Great Lakes. Environ Health Perspect 1995, 103:35-46.
68. Toxological profile for polychlorinated biphenyls (PCBs). US department of health and human services, Public Health Service. Agency for toxic substances and disease registry 2000.
69. Kimbrough R.D., Krouskas C.A. Human exposure to polychlorinated biphenyls and health effects: a critical synopsis. Toxicol Rev 2003, 22:217-233.
70. Schecter A., Birnbaum L., Ryan J.J., Constable J.D. Dioxins: an overview. Environ Res 2006, 101:419-428.
71. Whitlock J.P. Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Annu Rev Pharmacol 1990, 30:251-277.
72. Viluksela M., Bager Y., Tuomisto J.T., et al. Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD resistant rat strains. Cancer Res 2000, 60:6911-6920.
73. Pesatori A.C., Consonni D., Rubagotti M., Grillo P., Bertazzi P.A. Cancer incidence in the population exposed to dioxin after the "Seveso accident": twenty years of follow-up. Environ Health 2009, 8:39.
74. Caramaschi F., del Corno G., Favaretti C., Giambelluca S.E., Montesarchio E., Fara G.M. Chloracne following environmental contamination by TCDD in Seveso, Italy. Int J Epidemiol 1981, 10:135-143.
75. Kozhevnikova G., Kuzmin I., Roumak V., Karaulov A. Immune alteration in South Vietnamese exposed to Agent Orange. Dioxin '91-proceedings of the 11th international symposium on chlorinated dioxin and related compounds 1991, 17. Research triangle Park, North Carolina.
76. Jennings A.M., Wild G., Ward J.D., Ward A.M. Immunological abnormalities 17 years after accidental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Br J Ind Med 1988, 45:701-704.
77. Jung D., Berg P.A., Edler L., et al. Immunologic findings in workers formerly exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners. Environ Health Perspect 1998, 106:689-695.
78. Nagayama J., Tsuji H., Iida T., Hirakawa H., Matsueda T., Ohki M. Effects of contamination level of dioxins and related chemicals on thyroid hormone and immune response systems in patients with "Yusho". Chemosphere 2001, 43:1005-1010.
79. Kim H.A., Kim E.M., Park Y.C., et al. Immunotoxicological effects of Agent Orange exposure to the Vietnam War Korean veterans. Ind Health 2003, 41:158-166.
80. Sherr D. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and long term immunologic memory. Toxicol Sci 2004, 79:211-213.
81. Gavalchin J., Shanley P., Silvin C.J., et al. Estradiol (E2) treatment of male NZB X SWR (SNF1) mice produces immunological alterations associated with lupus like autoimmune nephritis in female SNF1 mice. Linking environmental agents and autoimmune diseases 1998, National Institute of environmental health sciences, (Abstract).
82. Holladay S.D., Mustafa A., Gogal R.M. Prenatal TCDD in mice increases adult autoimmunity. Reprod Toxicol 2011, 31:312-318.
83. Brooks S.C., Locke E.R., Soule H.D. Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem 1973, 248:6251-6253.
84. Garcia-Morales P., Saceda M., Kenney N., et al. Effect of cadmium on estrogen. J Biol Chem 1994, 269:16896-16901.
85. Brama M., Gnessi L., Basciani S., et al. Cadmium induces mitogenic signaling in breast cancer cell by an ERα-dependent mechanism. Mol Cell Endocrinol 2007, 264:102-108.
86. Bernard A., Lauwerys R., Gengoux P., et al. Anti-laminin antibodies in Sprague-Dawley and Brown Norway rats chronically exposed to cadmium. Toxicology 1984, 31:307-314.
87. Ohsawa M., Otsuka F., Takahashi K. Modulation of the immune response by trace elements. Trace elements in clinical medicine 1990, 165-171. Springer Verlag, Tokyo. H. Tomita (Ed.).
88. Markovits J., Linassier C., Fossé P., et al. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 1989, 49:5111-5117.
89. Yellayi S., Naaz A., Szewczykowski M.A., et al. The phytoestrogen genistein induces thymic and immune changes: a human health concern. Proct Natl Acad Sci USA 2002, 99:7616-7621.
90. Calemine J., Zalenka J., Karpuzoglu-Sahin E., Ward D.L., Lengi A., Ahmed S.A. The immune system of geriatric mice is modulated by estrogenic endocrine disruptors (diethylstilbestrol, alpha-zearalanol, and genistein): effects on interferon-gamma. Toxicology 2003, 194:115-128.
91. Verdrengh M., Jonsson I.M., Holmdahl R., Tarkowsky A. Genistein as an anti-inflammatory agent. Inflamm Res 2003, 52:341-346.
92. Parry J.P., Taylor D.D., Nakajima S.T., Gercel-Taylor C. Genistein reverses diminished T-cell signal transduction, induced by post-menopausal estrogen levels. Am J Reprod Immunol 2009, 61:26-33.
93. Yang Y., Nie W., Yuan J., et al. Genistein activates endothelial nitric oxide synthase in broiler pulmonary arterial endothelial cells by an Akt-dependent mechanism. Exp Mol Med 2010, 42:768-776.
94. Michnovicz J.J., Galbraith R.A. Cimetidine inhibits catechol estrogen metabolism in women. Metabolism: Clin and Exp 1991, 40:170-174.
95. Mueller S.O., Kling M., Arifin Firzani P. Activation of estrogen receptor alpha and ERbeta by 4-methylbenzylidene-camphor in human and rat cells: comparison with phyto- and xenoestrogens". Toxicol Lett 2003, 142:89-101. et al.
96. Routledge Edwin J., Odum J., Ashby J., Sumpter J.P. Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicol Appl Pharmacol 1998, 153:12-19.